In 1992, the first study on GLP-1 in humans was conducted, demonstrating that infusion of GLP-1 (aa 7–37) peptide induced insulin section and had antidiabetic effects in both patients with and without diabetes (16). The gene discussed is GLP1R; the disease is diabetes mellitus.